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ABSTRACT 
Liposomes are an efficient novel drug delivery system. They are used because of their structure which is stable and due to their ability to 
accommodate both lipophilic and hydrophilic drug. Various fascinating types of liposomes have been developed in recent past to further enhance 
their utility. Long-circulating liposomes or stealth liposomes are able to hide from the defence system of the body and circulate for a longer time in 
the blood. Targeted liposomes namely immuno- liposomes consists of antibodies conjugated on their surface to improve the specificity of the cell. 
Liposomes have been modified as per the conditions of pH and temperature, specifically designed to improve drug delivery to targeted tumor cells. 
Liposomes are being used in the treatment of various diseases and there are various liposomal drug formulations available today. Liposomes can be 
used as carriers for genetic materials such as antisense, DNA, RNA which are useful in the treatment of diseases. Liposomes are also efficient 
carriers of cytokines which further activate macrophages. This review provides the detailed insight of types and applications of liposomes and the 
potential challenges in the development of liposomal drug delivery systems. 
Keywords: Targeted, Long-circulating, pH sensitive, Cancer, Antimicrobial agent 




Liposomes are drug delivery systems which because of its organized 
structure can accommodate drugs depending on their solubility in 
aqueous as well as lipid phases. One of the features of liposomes is 
their ability to alter the biodistribution and pharmacokinetics of the 
drug associated. Liposomes are microscopic aggregates of highly 
ordered lipid molecules, dispersed in a hydrophilic solvent like 
water. Liposomes are amphiphilic having monolayer, one surface 
with polar head groups and other with fatty acid acyl chain. The 
monolayers are arranged in a lamella or a bilayer in which 
hydrophobic regions are sandwiched. This arrangement is similar to 
the phospholipids like phosphatidylcholines or lecithins which are 
the major component of the cell membrane. Liposomes take up the 
cylindrical shape and have a parallel arrangement but, a wedge 
shape is taken up by a liposome when there is a significant 
difference between the cross-sectional area of polar and non-polar 
regions. The differences may occur due to the electrostatic effects, 
arising because of the attractive or repulsive forces between 
adjacent head groups. In these conditions, curved structures are 
forcedly formed by amphiphiles, most common being the hexagonal 
phases (cylinders) and micelles (spheres to elongated rods). If the 
polar head group is broader than non-polar, the curvature will be 
positive and forms the outer surface of the curve. If the nonpolar tail 
is broader, the curvature will be negative with fatty acyl chains [1]. 
An extensive literature search was carried out to write this review. 
Some basic information on liposomes was collected from books. 
Most of the articles were collected from Science Direct, PubMed and 
Elsevier databases. Relevant articles were searched using keywords 
like liposomes, long circulating, pH sensitive, temperature sensitive, 
characterization, types of liposomes, applications of liposomes etc. 
Vast data was collected over the period of last 20 y to review the 
progressive developments in the field of liposome research. 
Morphology and nomenclature 
In dry state, the lamellar forming lipids exist in a dense crystalline 
form. The non-polar hydrocarbon chains are rigid and extend fully 
below a certain temperature and above this temperature, there is an 
increase in thermal excitation leading to distortion of chains. Above 
the transition temperature, the addition of water causes hydration 
of the polar heads of amphiphile and it rearranges into a lamellar 
form. There is diffusion of water through bilayer surface which 
causes a similar rearrangement of the lipid. The lipids arrange 
themselves into a series of parallel lamellae which by the addition of 
water is separated from the successor. When there is complete 
swelling of the liquid crystalline structure and equilibrium with 
excess water, closed packed multilamellar lipids are broken by mild 
agitation. 
These liposomes which are large and possess a number of adjacent 
concentric bilayers and alternate layers of water are multilamellar 
vesicles (MLV). The interlamellar distance increases between 
adjacent lamellae due to charge-charge repulsive forces when ionic 
strength of hydration media is low. This occurs when lipid contains a 
negatively charged amphiphile component. Hydration, when occurs 
undisturbed with gentle stirring, individual lamellae detach to form 
large unilamellar vesicles (LUV). The maximum curvature that a 
lipid bilayer can achieve decides the lower limit of liposome size. 
Natural phospholipids such as egg and soy lecithins have a size of 
around 21 nm. Small unilamellar vesicles (SUV) are single layered 
liposomes that have a size upper limit of around 100 nm [1]. 
Types of liposomes 
Long-circulating liposomes 
Stealth or long-circulating liposomes are sterically stable [2] and do 
not appear to the defence mechanism of the body mainly the Kupffer 
cells of liver and macrophages of the spleen [3]. The disadvantage of 
liposomes is the rapid clearance from the circulation, which can be 
avoided by using stealth liposomes [4]. It only takes minutes for 
intravenously administered drug to be engulfed by phagocytes and 
due to this, the drug does not reach the site of action. To increase 
circulation cohesive bilayers like disteroyl lecithin or sphingomyelin 
can be used [2]. The major reason for clearance is the adsorption of 
the blood macromolecules and their opsonization into the liposomal 
surface leading to phagocytosis [4]. 
Liposomes clear rapidly because of engulfment by the defence system 
or the disintegration due to plasma lipoprotein interaction. One of the 
reasons for the interaction with macromolecules is Van der Waals 
attraction. This hindrance can be resolved by sterical stabilisation. 
Sterical stabilization can be done by polyethylene glycol (PEG) 
modified phosphatidylethanolamine based lipid in the lipid 
preparation. Longer circulation is achieved by the liposome due to the 
dissociation of PEG-lipid from the layer which uses stronger 
hydrophobic anchors or polymerised bilayers. The electrostatic and 
hydrophobic interactions are prevented due to the high local 
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concentration of hydrated groups at the surface of PEG-liposomes [2]. 
Stealth liposome named Doxil is present in the market as doxorubicin 
hydrochloride for treating AIDS-related Kaposi’s sarcoma [4]. 
Targeted liposomes 
Targeted liposomes include conjugating antibodies to the surface of 
the liposomes resulting in improved cell specificity. These are known 
as immuno- liposomes. On the surface of the liposomes, sulfhydryl 
groups of reduced immunoglobulin M (IgM) are conjugated to 
maleimide groups on the surface of liposomes. Maleimide groups are 
formed on the surface by liposome preparation using N-(m-
malemidobenzoyl): dipalmitoyl phosphatidyl ethanolamine (2.5 
µmol), dipalmitoylphosphatidylcholine (25 µmol) and cholesterol 
(17.5 µmol). Immunoliposomes show a specific cell type that 
corresponds to the antibody in vitro, but the cytotoxicity of the drug 
could not be retained by formulation [4]. The preparation of tumor 
specific liposomes is done by anti-BCG monoclonal antibodies coupling 
to pH-sensitive liposomes. Modifications are done using succinylated 
polyglycidol (sucPG) to achieve binding specificity and internalization 
into cells by endocytosis. BCG-suc PG immuno- liposomes empty their 
contents into the cytoplasm by endosome fusion or fusion with 
liposomal membrane after target cell recognition and endocytic 
internalization [5]. The liposomal delivery to the liver parenchymal 
cell can be sustained and targeted by modifying distearoyl-
phosphatidylcholine (DSPC) and cholesterol (Chol) liposomes in the 
ratio of 60:40 with a galactosylated cholesterol derivative (Gal-C4-
Chol) and tween 20 or 1, 2-distearoyl-sn-glycero-3-phospho-
ethanolamine-N-polyethylene glycol (PEGx
Cationic liposomes 
-DSPE) when administered 
intravenously [6]. 
When the DNA is mixed simply with cationic SUV, an effective lipid-
DNA complex is formed. This occurs due to a positive charge as a 
cationic lipid is used for neutralization of extended, polyanionic chain 
of nucleic acid and forms a compact microstructure lipoplex. Each 
particle possesses a positive charge which helps to approach and 
induce an interaction with the cell membrane which has a negative 
charge and by the receptor-mediated endocytosis they gain entry [1]. 
pH sensitive liposomes 
pH-sensitive liposomes were first studied as an application which 
was designed to release their contents in a slightly decreased pH 
environment of 6 in a tumor tissue. They are used to improve the 
delivery of active substances to their site of action in the target cell. 
The components which at a physiological pH of 7.4 adopt a lamellar 
phase are used to form pH-sensitive liposomes. The pH is decreased 
to a critical value around 5.5 due to which liposomes become 
fusogenic and fuse with the endosomal membrane. The fusion 
occurs due to the transition from a lamellar phase to a hexagonal 
phase which causes the lipophilic part of the lipid structure to have a 
larger space. The important criterion for the selection of the 
compound is that with a decrease in pH it must change its molecular 
shape [7]. The disadvantage of conventional liposomes includes 
degradation of the contents and liposomes during endocytosis, as 
the endosomal pH is reduced to 5 or less at the lysosome stage and 
also due to the enzymic action. When pH sensitive liposomes are 
used, the transition of non-bilayer takes place between early and 
late endosomal stages which upset the stability of endosome and the 
contents are delivered to the cytoplasm [1].  
The major disadvantage of pH-sensitive liposomes is its poor 
stability in vivo, due to which there is a leakage in the large 
liposomes prepared by dioleoylphosphaidylenthanolamine (DOPE) 
and oleic acid at 37˚C in the presence of plasma and rapid clearance 
by the reticuloendothelial system. Leakage occurs due to the oleic 
acid loss into the plasma components. As a solution to the problem, 
liposomes with a double chain amphiphiles using 1, 2-dipalmitoylsn-
3-succinylglycerol was prepared which was stable and even after 
prolonged plasma incubation maintained their pH sensitivity [1]. 
Temperature sensitive liposomes 
For achieving the selective drug delivery action to tumor cells, 
temperature sensitive liposomes have been developed. Liposomes 
are prepared by the use of phospholipid mixtures having a transition 
temperature higher than body temperature by a few degrees. At 
temperatures near the transition temperature due to bilayer defects, 
the liposomes show increased permeability. When drugs containing 
cytotoxic drugs are injected into the systemic circulation and 
localized heat is applied externally to the target site, it causes the 
liposomes to release the drug to that area [1]. 
Modifying the liposomes with poly (N-isopropyl acrylamide) [poly 
(NIPAM)], results in the formation of temperature-sensitive 
liposomes. A hydrated coil to a dehydrated globule transition at 30˚-
35˚C in aqueous solution is exhibited by poly (NIPAM). The polymer 
is hydrophilic below the transition temperature but becomes 
hydrophobic above this temperature. Hence above the transition 
temperature, the liposomes are destabilized by polymer-liposome 
interaction. They are useful as a potential drug delivery system with 
temperature sensitivity, as the physiological temperature can be 
adjusted by copolymerization with hydrophilic comonomers [8]. 
Applications 
Cancer 
Undirected and ligand-targeted liposomes have been used to 
administer chemotherapeutic agents as well as peptides and 
proteins. Macrophages are activated and made tumoricidal by 
incorporating cytokines and other immunomodulators. The different 
anti-tumor effects are brought by using genetic materials like DNA, 
ribosomes, antisense molecules in liposomes. Most of these methods 
have given great outputs [1]. 
Doxorubicin 
The drug resistance in cancer therapy is a big obstacle to successful 
cancer treatment. Drug resistance is caused by defective drug 
transport through the cell membrane when, drug inactivation is 
increased or drug activation is decreased, change in the affinity or 
levels of target enzymes and increased level of DNA damage repair. 
Doxorubicin is an anthracycline anticancer agent used for breast, 
leukemia, ovarian cancer treatment. Stealth monensin liposome 
(SML) is used to increase the potency of Doxorubicin. Liposomes are 
prepared using cholesterol, stearyl amine, dipalmitoyl 
phosphatidylcholine (DPPC), disteroyl glycerophosphoethanolamine 
coupled with polyethylene glycol (DSPE-PEG) and encapsulating 
radioactive monensin. Monensin increases the strength of 
Doxorubicin and acts as an immunotoxin against human tumors. In 
vivo circulation of liposomes is increased by using polyethene glycol 
(PEG) synthetic derivatives. The tests performed by preparing 
several formulations helped in estimating the amount of monensin 
entrapped, particle size, stability and leakage. The stearylamine used 
increased the formulation stability by producing a positive charge 
on the liposome surface which led to electrostatic repulsion between 
the adjacent bilayer. Disteroyl glycerophosphoethanolamine coupled 
with polyethylene glycol (DSPE-PEG) leads to steric hindrance and 
hence the entrapment by the reticuloendothelial system (RES) was 
reduced. Cholesterol used was responsible for increasing the 
stability and decreasing leakage. The stealth monensin liposomes 
containing monensin at a concentration of 10-9
Paclitaxel 
M was used which, is 
a non-toxic concentration. No Golgi dilation was observed. 
Depending upon the nature and difference in various human tumor 
cell lines, stealth monensin liposomes increase the activity of 
Doxorubicin by 2-2400 times [9]. Ehrlich tumor cells were inhibited 
using liposomes containing doxorubicin in the ratio of 100:100:60:4. 
The drug was delivered to the tumor cell by endocytosis. The results 
showed the presence of high concentration of doxorubicin in the 
tumor cells. Thus liposomal doxorubicin is more effective against 
Ehrlich tumor cells [10]. 
In our lab, we have studied the effect of the composition of 
phospholipids on drug entrapment efficiency and pH sensitivity. 
Paclitaxel-containing liposomes of different phospholipid 
compositions were formulated and compared. Liposomes with 
phosphatidylcholine alone did not show pH sensitivity. Another 
formulation with phosphatidylcholine/dioleylphodphatidyl-
ethanolamine (8:2) released drug at pH 5.5, but was found to be 
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unstable at pH 7.5. On inclusion of CHEMS, the liposomes were 
stabilized at physiological pH, and released paclitaxel at a lower pH. 
Thus the formulation composed of phosphatidylcholine/ 
dioleylphodphatidylethanolamine/cholesteryl hemisuccinate (8:2:2) 
containing paclitaxel and lipids in the molar ratio of 1:30 (drug: 
lipid) has proved to be the most efficient pH sensitive system with 
94 % entrapment efficiency. This formulation showed 96% of drug 
release at pH 5 within 15 min [11]. It was further optimised by using 
Box‑Behnken design. The aim was to investigate the combined 
influence of 3 independent variables in the preparation of paclitaxel-
containing pH‑ sensitive liposomes. Independent variables selected 
were the molar ratio of phosphatidylcholine: ditolyl phosphatidyl-
ethanolamine (X1), the molar concentration of cholesteryl 
hemisuccinate (X2), and the amount of drug (X3). Liposomes were 
prepared by thin film hydration method and evaluated for the 
percent drug entrapment, vesicle size, and the pH sensitivity. The 
transformed values of the independent variables and the dependent 
variables were subjected to multiple regressions to establish a full 
model second order polynomial equation. F was calculated to 
confirm the omission of insignificant terms. The computer 
optimisation process and contour plots predicted the levels of 
independent variables for maximised response of percent drug 
entrapment with constraints on the vesicle size and the pH 
sensitivity [12]. 
Peptides 
Peptides show the properties of tumor recognition, tissue 
penetration, selective binding and internalising capacity by the 
cancer cells. These properties make them useful for delivering 
oligonucleotides, toxins and radioactive molecules. Peptides are not 
detected by the immune system and there are less or no known side 
effects. Cell-specific targeting can be achieved by incorporating the 
peptides into multicomponent complexes. Peptides show excellent 
tumor cell penetration. The cell penetrating peptide (CPP) 
formulations were prepared for selective drug delivery and to 
increase the circulation time in vivo without affecting the cell 
penetration. These are smart stimuli-sensitive preparations whose 
functions can be turned on or off by outer stimuli-sensitive 
polyethene glycol (PEG). To penetrate the cytoplasmic membrane 
barrier for drug delivery, octa-arginines are utilised and to resist the 
kinetic barriers, a removable coating from cholesterol anchored 
reduction-sensitive PEG is used. For the studies, liposomes with 
functional lipids attached to different cholesterol were prepared. 
The composition used was egg phosphatidylcholine (EPC)/ 
cholesterol (chol) in the ratio of 65:35 and the cholesterol 
percentage decreased with the use of functional lipids attached to 
different cholesterol. The solvent used was chloroform which was 
evaporated using rotary evaporator [13]. 
Docetaxel 
Docetaxel from taxane class of anticancer agents is a very important 
chemotherapeutic agent. Docetaxel induces a mitotic block at the 
metaphase or anaphase thereby inhibiting cell proliferation. 
Polymerization of stable microtubules is promoted, prevented from 
breaking apart and significantly affects the number of key cellular 
functions which depends on the turnover of tubulin. 
Since docetaxel is known to prevent the depolymerization of 
microtubules, it is cytotoxic against human ovarian, endometrial, 
colon and breast cancer. When compared with insoluble paclitaxel, 
docetaxel which is soluble shows more cytotoxicity. Taxane 
liposomes are either conventional or PEGylated (polyethene glycol) 
are prepared by forcing out multilamellar liposomes by using 
different cholesterol ratios in the phospholipid mixtures. For 
evaluation of in vitro stability, cytotoxic activity, pharmacokinetics 
and biodistribution, the composition of liposomes are optimised to 
obtain maximum stability and incorporating docetaxel. The 
formulation in which liposome composition was egg yolk 
phosphatidylcholine (ePC), phosphatidylglycerol (PG), cholesterol 
(chol) i. e ePC/PG/chol in the ratio of 9:1:2 which contains 
encapsulated docetaxel proved effective in reaching a good drug 
concentration. The inclusion of small amount of cholesterol did not 
have any negative effect on docetaxel as compared to paclitaxel. 
However large amount affected the stability. Docetaxel shows better 
solubility and less rigidity as it is a semi-synthetic derivative of 
paclitaxel in which benzoyl group is replaced by a tertiary butyl 
ester group. This may minimise hydrophobic interactions between 
cholesterol and docetaxel in a lipid vesicle. Sterically stabilised 
liposomes containing docetaxel was prepared by PEGylated 
(polyethylene glycol) liposomes/cholesterol in the ratio of 9:1:2:0:7. 
Both conventional and PEG encapsulated docetaxel at the highest 
dose was stable at 4˚C in the hydrated form. In fetal bovine serum at 
37 ˚C it was found to be unstable. 
Liposomal docetaxel shows same in vitro cytotoxicity and better 
pharmacokinetic properties. When further compared with the 
docetaxel in tween 80 formulation it was found that liposome 
containing docetaxel showed an increase in plasma drug 
concentration and the drug ADME (absorption, distribution, 
metabolism and excretion) was increased up to 24 h*. In docetaxel 
encapsulated PEGylated liposome, there is a need to increase the 
concentration of drug within lipid bilayer without affecting liposome 
stability [14]. 
Endelfosine 
Endelfosine is an anticancer agent which is an alkyl phospholipid 
analog. Endelfosine acts an anticancer agent by inducing cell 
apoptosis in tumor cell through a stress response from the 
endoplasmic reticulum and mitochondrial interaction. Endelfosine is 
known for dose-dependent rupture of red blood cells and toxic to 
bone marrow cell and other normal tissues. Therefore to remove 
side effects tumor-targeted delivery is adopted. The liposome 
surface is modified with AG73 peptides to improve delivery of 
endelfosine which is a lipophilic anticancer drug. The drug is 
delivered to the tumor cells which overexpress the syndecan 2 
which is a cell surface receptor. To test the cellular uptake due to the 
surface density of liposomes modified with AG73 peptides, 
conjugated AG73 peptide polyethylene glycol with a molecular 
weight of 2000 was synthesized and encapsulated into anionic 
liposomes which where fluorescence dye-labeled with different 
ligand densities such as 1, 2, or 5 mol% of total lipids. Increase in the 
cellular uptake of liposomes modified with AG73 peptides was 
proportional to the surface ligand density. For ligand mole 
percentages of 1, 2 and 5, the percentage cell positive for AG73 
modified liposome was 19.8±2.0%, 23.1±5.0%, and 99.2±1.0% 
respectively. The modified liposomes encased with endelfosine 
destroyed the cancer cells better than the unmodified liposomes. 
When tests were performed in tumor-bearing mice which, were 
administered intravenously with the AG73 peptide modified 
liposomes, exhibited greater accumulation of 2.1-fold in tumor cells 
as compared to unmodified liposomes [15]. 
Methotrexate 
PEGylated methotrexate liposomes containing hydrogenated soy 
phosphatidylcholine and cholesterol have been prepared to achieve 
the targeted delivery to the tissues or organs that need it most. 
Attempts were made to enhance the encapsulation by use of non-
ionic surfactants such as tween-80, tween-20 and solubility 
enhancers such as β-cyclodextrin [16]. 
Antimicrobial agents 
Bacterial, fungal, viral, parasitic diseases can be treated using 
liposomes by delivering the immunomodulators to the macrophages. 
The liposomes containing cytokines such an interferon γ (INF-γ) 
which activates macrophages get the response of infectious diseases. 
Microorganisms that have undergone phagocytosis affects the host 
cell and start multiplication and shows resistance to treatment by 
antimicrobial drugs due to less penetration or when intracellular 
activity is reduced. The delivery of liposomes across the cell can be 
achieved by the phagocytic activity. It also protects the host from 
drug toxicity. Patients suffering from cancer, diabetes, AIDS have a 
high incidence of acquiring fatal systemic fungal infections and 
hence liposomes form an effective drug delivery system to treat such 
patients [1]. 
Amphotericin B 
Amphotericin B is a polyene macrolide antibiotic used in the 
treatment of fungal infections of systemic nature, regardless of their 
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toxicity. Molecular localization of amphotericin B entrapped in 
liposomes coated with polyethylene glycol (PEG) has been studied. 
The liposome composition included dipalmitoylphosphatidylcholine 
(DPPC), cholesterol (chol), distearoyl-N-(monomethoxy poly 
(ethylene glycol)succinyl) phosphatidylethanolamine-conjugated 
with polyethylene glycol (DSPE-PEG2000)
The effect of distearoylphosphatidylethanolamine conjugated with 
polyethylene glycol (DSPE-PEG
 which was hydrated with 
9% solution of sucrose and extruded. There was an increase in 
amphotericin B amount with the increased addition of DSPE-PEG 
while the amount decreased with the increase in cholesterol (chol). 
Methods like PEG/dextran two-phase partitions, potassium 
permeability measurement, circular dichroism (CD) spectroscopy 
and fluorescence quenching measurement were used to study 
molecular localization. According to the results, amphotericin B 
localization in PEG-liposomes are of two types, one which is the 
complex of amphotericin B with DSPE-PEG on the surface of 
membrane and other is amphotericin B in a pore form in the 
hydrophobic core of liposome membrane. Amphotericin in both 
aggregated and monomeric state was present in PEG liposomes [17]. 
1900
One comparing the biodistribution of DSPE-PEG and amphotericin B 
liposome (type 2) and amphotericin B liposome, it was found that 
biodistribution of DSPE-PEG and amphotericin liposomes (type 2) 
was increased as compared to amphotericin B liposome. In DSPE-
PEG and amphotericin B liposome (type 2), 30% of the injected dose 
of amphotericin B was circulating in intact liposome whereas for 
amphotericin B liposome 6% was circulating at 24 h* after 
administration [18]. 
) on toxicity and biodistribution 
of amphotericin B was studied in mice. Two formulations i.e. 
liposomes containing DSPE-PEG and amphotericin B (type1 and type 
2) and amphotericin B liposome without DSPE-PEG and also 
amphotericin B-deoxycholate (AMB-DOC) was compared for 
toxicity. The maximum tolerated a dose of AMB-DOC is 0.8 mg/kg 
per day which is shown in terms of death in the treatment of 5 
consecutive days or increase in the monitoring parameters of renal 
and hepatic functions. The least toxic was amphotericin B liposome 
with the maximum tolerated dose 11 mg/kg per day. The DSPE-PEG 
containing amphotericin B liposome (type 1) was toxic similar to 
AMB-DOC. DSPE-PEG and amphotericin liposomes (type 2) had 
reduced toxicity with a maximum tolerated a dose of 9 mg/kg per 
day.  
Leishmania infection 
Liposomes are an effective solution for the treatment of 
mononuclear phagocytes linked infectious diseases. Leishmaniasis is 
a fatal parasitic disease cause by protozoa leishmania spp which is 
an intramacrophage. The predominant drug used for treating 
leishmaniasis is antimonial even though they are toxic and their 
mechanism of action is unknown. When the anti-leishmanial agents 
are incorporated into the liposomes for delivery at the site of 
infection, they are more effective, have reduced toxicity and a few 
adverse effects. The study was carried out to develop novel 
liposomes containing meglumine antimoniate (MA), to study their 
effect on leishmaniasis and macrophageal uptake. 50% inhibitory 
concentration (IC50)
Antisense 
, when determined proved that MA containing 
liposomes were ≥10 -fold more effective with higher activity and 
increase in selectivity index by 5-fold and decrease in toxicity by 
macrophages. When MA was incorporated in liposomes containing 
phosphatidylserine, the concentration required was ≥40-fold lower 
to kill 100% intracellular amastigotes as compared to the free drug. 
Infected macrophages increased the uptake of fluorescent liposomes 
after a short incubation time as compared to the non-infected ones 
when studied through fluorescence microscopy. Thus the study 
proves that the use of MA incorporated liposomes is more effective 
for the treatment of leishmaniasis [19]. 
Antisense are oligonucleotides (ONs) with a complimentary base 
sequence which are RNA specific. They prevent gene expression and 
are hence used in the treatment of cancer and inflammatory 
diseases. Oligonucleotides have poor solubility, weak cellular 
penetration and poor delivery to the cytoplasm. To solve this 
problem, anionic pH sensitive liposomes are prepared. Liposome 
endocytosis leads to the formation of intracellular vacuole i.e. 
endosome which undergoes fusion with lysosomes and inside of 
which the pH reduces due to a proton pump. The acidic pH 
destabilizes the pH-sensitive liposomes and fuses with an 
endosomal membrane which leads to drug delivery in the cytoplasm 
[20]. 
Antisense oligonucleotides (asODNs) such as DNA or RNA, small 
interfering RNA i.e. siRNA and miRNA, DNAzymes, ribozymes which 
are oligonucleotides with catalytic activity are used to control gene 
expression [21]. Gene expression control by nucleic acids occurs by 
two mechanisms. Gene expression interference by antisense is done 
by preventing protein translation from mRNA. Short gene fragments 
of base sequence 15 to 20 are oligonucleotides (ONs) having a 
complementary sequence to target the mRNA. Hybridization of 
antisense oligonucleotides with mRNA occurs by base pairing by 
Watson and Crick which blocks protein translation and is known as 
translational arrest [19]. The second mechanism involves the 
activation of an enzyme RNase H which consumes the hybrid mRNA. 
ONs can also form a triple helix with double-stranded DNA and 
thereby control the gene expression or restrict transcription [21]. 
siRNA 
Small interfering RNA were first observed in plants in the 1980s, 
later in 1998 in Caenorhabditis elegans and further observed in 
mammals which led to their research [22]. They are capable of 
silencing post-transcription of all genes which are homologous and 
transgenes by incorporating long double-stranded RNA in various 
hosts. 
The series of events that lead to the discovery of mRNA include, inside 
the cell the metabolism of double-stranded RNA (dsRNA) occurs leading 
to 21-23 interfering RNAs by the action of ribonuclease. Two RNA 
strands are unwound by a helicase activity when siRNA binds to RNA 
which induces silencing complex (RISC) and thus antisense binds to the 
focused RNA molecule. Hydrolysis of the target RNA at antigen binding 
site takes place due to endonuclease activity. Target RNA is destroyed 
when a single stranded RNA binds to the target RNA by Watson and 
Crick base pairing and activates the enzyme ribonuclease [23]. 
To improve solubility, distribution and circulation of 
oligonucleotides like siRNA and microRNA (miRNA), the liposomes 
are modified using polyethylene glycol (PEG). However, the long 
PEG chain reduces the efficient hybridization. The short PEG chain 
when used did not affect the gene silencing when studied in vitro 
[24]. The ability of antisense silencing of genes can be improved if 
liposomes are made of polyalkyleneoxide (poly (propylacrylic acid) 
varying in the grafting limit. The complexes with poly (propylacrylic 
acid) and polyalkyleneoxide, enhance the gene silencing in A20780 
ovarian tumor cells [25]. 
Herpes simplex virus-thymidine kinase 
Cancer cell targeting could be achieved through endothelial cells. 
Cationic liposomes carry a reporter gene i.e. lacZ; β-galactosidase. 
Sensitive liposomes are used to transfer a viral enzyme herpes 
simplex virus thymidine kinase (HSV-TK) to which ganciclovir binds 
and is phosphorylated. Ganciclovir triphosphate gets encapsulated 
into DNA that is elongated and acts as a pseudo base which leads to 
chain termination and cell apoptosis. The advantage is that, 
ganciclovir terminates the dividing cells and the liposome causes the 
DNA insertion that stays for a short time [26]. 
Leukemia 
In leukemia there is an overexpression of the BCl2 gene and the 
development of cancer can be prevented if the BCl2 gene is reduced. 
Efficient liposomes have been prepared with good stability, 
specificity and toxic effects for the leukemia cells. The liposome 
formulation was composed of antisense oligonucleotides of which, 
the complex was formed with either cationic liquid, DOTAP (1,2-
dioleoyl-3-trimethylammoniumpropane), polyethyleneimine and 
polyethylene glycol modified liposome incorporation. The liposome 
surface is covered with a biomarker expressed on leukemia cell 
surface i.e. CD20, which are covalently bonded antibody recognizes. 
The expression of BCl2 gene is suppressed by the resulting immuno- 
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liposomes. The polyplex or lipoplex liposome formulations 
combined with antibodies are efficient carriers for oligonucleotides 
(ONs) into human tumor cells [21]. 
The liposomes efficiently delivering drugs to the liver tissues are 
prepared by conjugation with N-acetyl galactosamine. Physical 
properties such as particle size, specific ligand targeting when 
modified can be used to enable selective targeting for tumor cells. 
The barriers include endothelial, cellular membranes, endosome and 
drug accumulation in some other organ. Blood brain barrier of the 
brain has to be crossed for oligonucleotide therapy of nervous 
disorders. Instead of using N-acetylgalactosamine (GAINAc), mellitin 
like polymer is used to attach the small interfering RNA (siRNA) 
which shows degradation in an acidic endosome environment. These 
additional PEG-masking ligand carriers called dynamic 
polyconjugate undergo a cleaving at an acidic pH and they release 
the cationic polymer charge which was masked previously. This 
method is designed to achieve the increased siRNA escape from 
endosome through an effect known as the proton sponge effect. The 
proton sponge effect occurs when; hydrogen ion influx is induced by 
water leading to endosome swelling due to which they disrupt [27]. 
Vancomycin hydrochloride 
Vancomycin hydrochloride (VANH) is used in the treatment of 
osteomyelitis, is water soluble, glycopeptide antibiotic. It is used for the 
treatment of bacterial infections of the bone and the bone marrow, due 
to the contamination from injury, surgery or device fixation of 
orthopedic origin. VANH is incorporated into the liposomes to change a 
drug’s bio-distribution, to improve therapeutic efficacy and reduce its 
toxicity. The liposomes were prepared with aim of gaining encapsulation 
efficiency (EE), a decrease in nephrotoxicity, increase circulation time in 
blood and efficient antimicrobial activity. 
The liposome composition included soybean lecithin, cholesterol by 
the method of reverse phase evaporation. The experimental studies 
stated the optimum encapsulation efficiency was 40.78±2.56% and 
188.4±2.77 nm was the mean particle size. VANH-liposomes showed 
sustained release characteristics when studied in vitro. The in vivo 
studies were carried out by administering the mice with VANH-
liposome intravenously which improved the mean resistance time 
(MRT) and AUC when compared to solution had increased 
significantly. The VANH accumulating in kidney was highly reduced 
by the VANH-liposomes when bio distribution studies were carried 
out intravenously and thereby reducing nephrotoxicity [28]. 
Liposomal inhales 
The pulmonary route is a promising drug delivery route. The 
carriers used for this purpose are target selective and can control 
drug release. The advantages of the carrier system include 
decreased drug toxicity, increased the stability of the drug, and the 
local irritation is prevented. Nebulisers are used in the actual 
liposome formulation for inhalation. The nebulisers used include 
ultrasonic, air-jet and passively vibrating mesh nebulisers. The drug 
models with different molecular weights were used. Hydration 
method was used to prepare liposomes loaded with water soluble 
drug. Characterization of liposome was done by an extrusion 
method, which consisted of an extruder with 100 nm filter of 
polycarbonate. Various nebulisers were studied to find out which 
one would efficiently atomize the liposome preparation. Anderson 
cascade impactor (ACI) was used to measure the physical inhalation 
properties of liposomes. Through the studies, the most efficient 
nebulizer to deliver liposomal formulation to pulmonary parts was 
found to be air-jet nebulizer. The increase in liposome size caused 
leakage and decrease in lung delivery efficiency. Also the drugs with 
small molecular size showed leakage when atomized as compared to 
large molecular size. The leakage of small molecular size drugs could 
be decreased by decreasing particle size up to 100 nm. The 
liposomal inhales could be prepared using air-jet nebulizer while 
taking into consideration the particle size [29]. 
Epilepsy 
Gossypin liposomes have been prepared in a research study. They 
studied the efficacy of liposomal gossypin formulations by 
administering the formulation at two doses by the intravenous 
route. The studies were carried out in mice treated with 
pentylenetetrazole to induce seizures. They reported that the 
increased levels of malondialdehyde and glutathione were reduced 
and liposomal gossypin suppressed the progression of kindling in 
mice. These results suggest that liposomal gossypin appears to 
possess protective activity against kindling in mice [30]. 
Acne vulgaris 
Liposomal gel of nadifloxacin have been prepared in order to 
achieve better permeation and high drug retention into the deeper 
layers of the skin for effective treatment of acne vulgaris [31]. 
Liposome characterization 
Characterization of liposomes can be done in a number of ways 
which depends on the system aspects. These aspects show relation 
to the liposome structure, the number of bilayers or lamellarity, 
appearance and potential of the surface. Other relation is with 
liposome stability, which is concerned with the changes in vesicle 
size, storage, and vesicle ability to keep the entrapped drug intact in 
any medium like buffer or biological fluids. When unsaturated 
phospholipids containing liposomes are modified, the extent of 
modification must be determined during production or storage. 
Liposome structure 
Vesicle size can be estimated using the hydrodynamic methods like 
gel exclusion chromatography, or proton correlation spectroscopy, 
the value obtained is in terms of z average mean in nanometers or 
micrometers. The vesicle size distribution is given by polydispersity 
index. Surface charge on the vesicles are determined by the zeta 
potential (zP) and is useful in liposome formulations in which the 
drug to be encapsulated is charged which modifies the overall 
surface charge. The number of bilayers also termed as liposome 
lamellarity is estimated using small angle X-ray scattering which 
analyses whether the bilayers in the liposome are non-concentric 
like multilamellar vesicles. Structural or morphological studies are 
observed in varying conditions using light microscopy (large 
unilamellar vesicles and multilamellar vesicles) and electron 
microscopy. For samples in suspension, transmission electron 
microscopy is used which detects unilamellar, multilamellar and 
oligolamellar liposomes. Freeze-fracture electron microscopy 
(FFEM) is known to give a three-dimensional image of liposomes in 
suspension. 
When spectroscopy is used for estimating turbidity of liposome 
suspension, calibration curves are used to estimate approximate 
vesicle size or concentration. The interaction of phospholipid polar 
heads with the counter ions and hydration can be estimated using 
Fourier transformation methods. Infrared or Raman spectroscopy 
can be used for estimating the dynamics and the structure of 
phospholipid acyl chains of the liposome, transition temperature can 
be estimated using nuclear magnetic resonance (NMR) and electron 
paramagnetic resource (EPR) [1]. 
Light microscopy 
As restricted by the wavelength of light, a standard light microscope 
can resolve the structures that are 0.2 µm and larger. A light 
microscope consists of a light source, condenser lens and an 
eyepiece. Modern microscopes are compound microscopes with 
more than one objective lens varying from 0.5-100. Optically 
corrected immersion oil is used. There is image degradation due to 
the diffraction in a microscope having an objective magnification of 
40X, 63X and 100X.3X to 1,500X. The image is viewed directly and 
can be recorded either by an attached video camera or by an 
attached camera photographically. 
Imaging modes 
Viewing the samples in a light microscopy is done using bright field 
imaging which uses optical density differences and a light colour that 
passes through the sample. The dark field is used for observing the 
small particulates and by background reversing and reversing the 
sample optical density increases the contrast. A phase contrast 
condenser can be utilized to increase the sample contrast when a 
phase shift between the transmitted and the scattered light passing 
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through the sample is introduced. The three-dimensional images of 
light microscopy samples can be obtained by Hoffman modulation optics 
that uses a polarizer condenser. Analysis of polymers in a crystalline 
state is achieved by polarized light microscopy. Confocal light 
microscopes are special instruments that can penetrate thick samples 
and this is achieved when the plane of focus of the objective lens is 
controlled with stepper motors that are computer regulated [32]. 
Transmission electron microscopy 
Transmission electron microscopy (TEM) is used to resolve 
structures having a small dimension less than 0.2 nm with the 
magnification range of less than 500 fold to million fold. TEM uses a 
heated filament that emits electron which is focused on obtaining 
images. TEM consists of lens in the form of electromagnets which 
bend the path of electrons. The electromagnets are also responsible 
for the electron acceleration and the energies used are in 60 to 100 
kV range. 
An aperture at the condenser limits the electron beam diameter 
which reaches the sample. There is an interaction between the 
atoms of the sample and the incident electron. There is a difference 
in the sample contrast due to the energy difference of electrons, 
occurring due to the atomic interactions. The aperture at the 
condenser controls the sample contrast. The objective lens focuses 
the beam of electron and the image is enlarged for observing 
through binoculars [32]. 
Scanning electron microscopy 
The scanning electron microscopy (SEM) provides a three-
dimensional information of macro (0.1-10 mm), meso (1-100 µm) 
and micro (10-1000 nm) structures in a micrograph. The particle 
size determination can be achieved using this technique. SEM gives a 
resolution of 3 nm and the range of magnification is less than 30-fold 
to 300,000 fold. There is an acceleration of electrons emitted by a 
heated filament or when the lanthanum hexaboride crystal is excited 
at a voltage of 1-30 kV. After the electron is incident with the sample, 
a number of electrons are emitted with energy differences. The 
inelastic scattering from atoms at the sample surface leads to the 
formation of secondary electrons having low energy range of 0-50 
eV. The secondary electrons are collected by the detector which then 
gives a three-dimensional image. 
The electrons due to the elastic scattering from the atom deep inside 
the surface are known as backscattered electrons and have high 
energy range. These are useful to distinguish between the atoms 
having a large difference in atomic number. The signals by the 
secondary, backscattered and X-ray (simple interaction with probe 
beam) are collected by the detectors, processed, amplified and 
displayed on the monitor [32]. 
Photon correlation spectroscopy: determining particle size 
The photon correlation spectroscopy (PCS) measures the fluctuation 
intensity which is time dependent due to the Brownian motion of 
the particles in a scattered laser light. The mathematical process 
called correlation is carried out which measures the similarity 
between the signal and the separated signal by time decay. There is 
correlation decay due to randomness as the signals become out of 
phase with each other. 
Nuclear magnetic resonance 
By using nuclear magnetic resonance (NMR), the signal of 
phosphorus NMR of liposomes is measured before and after adding 
manganese ions in the mixture. Phosphorus in the outer surface of 
liposome interacts with the manganese ions which lead to the 
resonance signal broadening beyond detection. There are two peaks 
formed, one where the phosphorus interacts with manganese ions 
and other where there is no interaction as the phospholipid groups 
are within the vesicle and does not come in contact with the 
manganese ions. 
The number of phospholipids in the outer layer can be estimated by 
comparison between the two signals. This technique exhibits the 
disadvantage that the negatively charged liposomes may undergo 
fusion due to the manganese ions causing a leak and interferes with 
the assay [33]. 
Regulatory guidelines 
Description and characterization 
The liposomal formulations should be characterized for position 
specificity, fatty acid composition, and the structural proof must be 
provided for well-defined synthetic or semisynthetic lipids, e. g. 
dimyristoyl phosphatidylcholine (DMPC). The lipid composition is 
studied in terms of percentage of lipid and fatty acid, the positional 
specificity of the acyl side chain, and the degree of fatty acid 
unsaturation. 
Lipid component manufacture 
Depending on whether the lipid utilized is naturally derived, 
synthetic or semi-synthetic information for manufacture must be 
provided. 
For synthetic and semi-synthetic lipids 
Complete information of the process and the purification procedure 
must be provided. The starting material specifications must be given 
for raw materials, reagents and solvents. If applicable, the controls 
for intermediates and critical steps which include controls that 
provide positional specificity of acyl chains must be mentioned. 
For naturally derived lipids 
The biological source should be given if the lipid is obtained from 
the animal source along with the information of the country of 
origin. It is required to provide information on the extraction and 
the purification procedures, as applicable. Information must be 
provided to ensure the removal, inactivation or avoidance of virus, 
animal proteins etc., wherever applicable. Appropriate 
manufacturing controls must be practised for avoidance or removal 
of pyrogenic material and bacterial endotoxins and the required 
description of the following must be provided. 
Lipid component specifications: The useful lipid component must be 
distinguished from the lipids with similar structures by the identity test. 
The stability-indicating analytical procedure must be the basis of the 
assay. The validated analytical procedure with the information of 
validation must be provided. The information on impurity testing must 
be provided. For natural lipids, other tests to be provided are the degree 
of unsaturation of fatty acid side chain, the content of counter ion and 
divalent cation limits. For synthetic lipids, other tests that can be 
included are trans fatty acid, free fatty acid, peroxides, 
lysophospholipids, the content of counter ions and the divalent cation 
limits. It is required to provide information about the amount of impurity 
in final liposome drug product, structural alerts and the know toxicities 
of impurity. The impurities can be detected by comparing lipid under 
test with a reference standard using suitable analytical technique e. g. 
High-performance liquid chromatography (HPLC). 
Stability 
The stability studies must be conducted that includes stress testing at 
high and low temperature, the pH and oxygen to obtain storage 
conditions, the degradation profile determination and the appropriate 
stability-indicating analytical procedure development [34]. 
CONCLUSION 
The researchers on liposomes have been going on since many years 
and are still prevalent. The aim of incorporating both hydrophilic 
and lipophilic drugs has been achieved through liposomes. Their 
structural stability and various modifications like pH sensitivity, 
temperature sensitivity, and sterical stabilization make them an 
efficient drug delivery system. The liposomes have proved to be a 
good drug delivery system for anti-cancer drugs and their 
applications have been increased significantly. Liposomes have also 
proved efficient in acting as drug delivery system for microbial 
infections in inhalation preparations. Target specific drug delivery is 
an important characteristic of liposomes. Liposomes must be 
formulated and characterised properly as per the intended use and 
the regulatory requirements. There is vast scope for research in 
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liposomes to improve their chemical and physical stability and to 
develop the sterilisation methods to enhance their clinical utility. 
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